Clinical trials in peripheral vascular disease: Pipeline and trial designs: An evaluation of the ClinicalTrials.gov database

Circulation

Volumn 130, Issue 20, 2014, Pages 1812-1819

  Subherwal, Sumeet ^a   Patel, Manesh R ^a   Chiswell, Karen ^a   Tidemann Miller, Beth A ^a,b   Jones, W Schuyler ^a   Conte, Michael S ^c   White, Christopher J ^d   Bhatt, Deepak L ^e   Laird, John R ^f   Hiatt, William R ^g   Tasneem, Asba ^a   Califf, Robert M ^a  

^a DUKE UNIVERSITY HEALTH SYSTEM   (United States)

^b NORTH CAROLINA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d JOHN OCHSNER HEART AND VASCULAR INSTITUTE   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical trials as topic; Peripheral vascular diseases; Prevention and control; Registries

Indexed keywords

PLACEBO;

AGED; ARTERY DISEASE; ARTICLE; BEHAVIOR THERAPY; CEREBROVASCULAR ACCIDENT; CLINICAL PRACTICE; CLINICAL TRIAL; DATA BASE; DEEP VEIN THROMBOSIS; HUMAN; INTERVENTION STUDY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; PERIPHERAL VASCULAR DISEASE; PIPELINE; POPULATION; PREVALENCE; PRIORITY JOURNAL; STUDY DESIGN; ULCER; UNITED STATES; VASCULAR DISEASE; VEIN DISEASE; AMPUTATION; CLINICAL TRIAL (TOPIC); DEVICE APPROVAL; DOUBLE BLIND PROCEDURE; EVALUATION STUDY; FACTUAL DATABASE; FINANCIAL MANAGEMENT; GEOGRAPHIC MAPPING; HEALTH CARE DELIVERY; INTERNET; METHODOLOGY; PATIENT SELECTION; PERIPHERAL ARTERIAL DISEASE; PERIPHERAL VASCULAR DISEASES; PROCEDURES; STATISTICS AND NUMERICAL DATA; STROKE; TRENDS; UTILIZATION; VENOUS INSUFFICIENCY;

AMPUTATION; CLINICAL TRIALS AS TOPIC; DATABASES, FACTUAL; DEVICE APPROVAL; DOUBLE-BLIND METHOD; GEOGRAPHIC MAPPING; HEALTH SERVICES ACCESSIBILITY; HUMANS; INTERNET; PATIENT SELECTION; PERIPHERAL ARTERIAL DISEASE; PERIPHERAL VASCULAR DISEASES; PLACEBOS; RESEARCH DESIGN; RESEARCH SUPPORT AS TOPIC; STROKE; UNITED STATES; VENOUS INSUFFICIENCY;

EID: 84922393847     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.114.011021     Document Type: Article

References (26)

1. Mahoney EM, Wang K, Keo HH, Duval S, Smolderen KG, Cohen DJ, Steg G, Bhatt DL, Hirsch AT; Reduction of Atherothrombosis for Continued Health (REACH) Registry Investigators. Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States. Circ Cardiovasc Qual Outcomes. 2010;3:642-651.
2. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD): TASC Working Group: TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg. 2000;31(pt 2):S1-S296.
3. Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrøm J. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost. 2007;5:692-699.
4. Institute of Medicine. Initial National Priorities for Comparative Effectiveness Research. Washington, DC: National Academies Press; 2009.
5. Tepe G, Zeller T, Albrecht T, Heller S, Schwarzwälder U, Beregi JP, Claussen CD, Oldenburg A, Scheller B, Speck U. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med. 2008;358:689-699.
6. Rogers JH, Laird JR. Overview of new technologies for lower extremity revascularization. Circulation. 2007;116:2072-2085.
7. Katzen BT, Dake MD, MacLean AA, Wang DS. Endovascular repair of abdominal and thoracic aortic aneurysms. Circulation. 2005;112:1663-1675.
8. Tateishi-Yuyama E, Matsubara H, Murohara T, Ikeda U, Shintani S, Masaki H, Amano K, Kishimoto Y, Yoshimoto K, Akashi H, Shimada K, Iwasaka T, Imaizumi T; Therapeutic Angiogenesis using Cell Transplantation (TACT) Study Investigators. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet. 2002;360:427-435.
9. Matoba S, Tatsumi T, Murohara T, Imaizumi T, Katsuda Y, Ito M, Saito Y, Uemura S, Suzuki H, Fukumoto S, Yamamoto Y, Onodera R, Teramukai S, Fukushima M, Matsubara H; TACT Follow-up Study Investigators. Longterm clinical outcome after intramuscular implantation of bone marrow mononuclear cells (Therapeutic Angiogenesis by Cell Transplantation [TACT] trial) in patients with chronic limb ischemia. Am Heart J. 2008;156:1010-1018.
10. Buller HR, Cohen AT, Davidson B, Decousus H, Gallus AS, Gent M, Pillion G, Piovella F, Prins MH, Raskob GE; van Gogh Investigators. Idraparinux versus standard therapy for venous thromboembolic disease. N Engl J Med. 2007;357:1094-1104.
11. Bauersachs R, Berkowitz SD, Brenner B, Buller HR, Decousus H, Gallus AS, Lensing AW, Misselwitz F, Prins MH, Raskob GE, Segers A, Verhamme P, Wells P, Agnelli G, Bounameaux H, Cohen A, Davidson BL, Piovella F, Schellong S; EINSTEIN Investigators. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med. 2010;363:2499-2510.
12. Eberhardt RT, Raffetto JD. Chronic venous insufficiency. Circulation. 2005;111:2398-2409.
13. McCray AT, Ide NC. Design and implementation of a national clinical trials registry. J Am Med Inform Assoc. 2000;7:313-323.
14. De Angelis C, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, Kotzin S, Laine C, Marusic A, Overbeke AJ, Schroeder TV, Sox HC, Van Der Weyden MB; International Committee of Medical Journal Editors. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. N Engl J Med. 2004;351:1250-1251.
15. Tasneem A, Aberle L, Ananth H, Chakraborty S, Chiswell K, McCourt BJ, Pietrobon R. The database for aggregate analysis of ClinicalTrials. gov (AACT) and subsequent regrouping by clinical specialty. PLoS One. 2012;7:e33677.
16. Califf RM, Zarin DA, Kramer JM, Sherman RE, Aberle LH, Tasneem A. Characteristics of clinical trials registered in ClinicalTrials.gov, 2007- 2010. JAMA. 2012;307:1838-1847.
17. Kong DF. Contemporary clinical research in adult cardiovascular medicine: a perspective from ClinicalTrials.gov. Poster presented at: Society for Clinical Trials 33rd Annual Meeting; May 20-23, 2012; Miami, FL. http://www.ctti-clinicaltrials.org/files/documents/StateOfClinicalTrials-Poster-AdultCardio.pdf. Accessed February 1, 2014.
18. Alexander KP, Kong DF, Starr AZ, Kramer J, Chiswell K, Tasneem A, Califf RM. Portfolio of clinical research in adult cardiovascular disease as reflected in ClinicalTrials.gov. J Am Heart Assoc. 2013;2:e000009.
19. Jones WS, Patel MR, Dai D, Subherwal S, Stafford J, Calhoun S, Peterson ED. Temporal trends and geographic variation of lower-extremity amputation in patients with peripheral artery disease: results from U.S. Medicare 2000-2008. J Am Coll Cardiol. 2012;60:2230-2236.
20. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM Jr, White CJ, White J, White RA, Antman EM, Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113:e463-e654.
21. Rooke TW, Hirsch AT, Misra S, Sidawy AN, Beckman JA, Findeiss LK, Golzarian J, Gornik HL, Halperin JL, Jaff MR, Moneta GL, Olin JW, Stanley JC, White CJ, White JV, Zierler RE; Society for Cardiovascular Angiography and Interventions; Society of Interventional Radiology; Society for Vascular Medicine; Society for Vascular Surgery. 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2011;58:2020-2045.
22. Watson L, Ellis B, Leng GC. Exercise for intermittent claudication. Cochrane Database Syst Rev. 2008:CD000990.
23. Goodney PP, Beck AW, Nagle J, Welch HG, Zwolak RM. National trends in lower extremity bypass surgery, endovascular interventions, and major amputations. J Vasc Surg. 2009;50:54-60.
24. Cohen AT, Davidson BL, Gallus AS, Lassen MR, Prins MH, Tomkowski W, Turpie AG, Egberts JF, Lensing AW; ARTEMIS Investigators. Efficacy and safety of fondaparinux for the prevention of venous thromboembolism in older acute medical patients: randomised placebo controlled trial. BMJ. 2006;332:325-329.
25. US Food and Drug Administration. Medical devices: removing retrievable inferior vena cava filters: initial communication. http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ucm221676.htm. Issued August 9, 2010. Updated August 22, 2013. Accessed September 6, 2013.
26. Subherwal S, Anstrom KJ, Jones WS, Felker MG, Misra S, Conte MS, Hiatt WR, Patel MR. Use of alternative methodologies for evaluation of composite end points in trials of therapies for critical limb ischemia. Am Heart J. 2012;164:277-284.